STAAR SURGICAL CO
Financial highlights
| Metric | FY 01/02/26 | FY 12/27/24 | FY 12/29/23 | FY 12/30/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $239.4M | $313.9M | $322.4M | $239.4M | $230.5M |
| Cost of revenue | $57.0M | $74.3M | $69.8M | $61.0M | $51.8M |
| Gross profit | $182.4M | $239.6M | $252.7M | $223.4M | $178.6M |
| Selling, general & administrative | $274.1M | $252.2M | $224.6M | $179.6M | $145.3M |
| Research and development | $40.1M | $45.3M | $40.5M | $36.0M | $33.9M |
| Operating income | -$91.7M | -$12.6M | $28.1M | $43.8M | $33.3M |
| Pretax income | -$82.3M | -$9.1M | $33.7M | $45.6M | $31.3M |
| Income tax expense | -$1.8M | $11.2M | $12.3M | $5.9M | $3.8M |
| Net income | -$80.4M | -$20.2M | $21.3M | $39.7M | $27.5M |
| Balance Sheet | |||||
| Cash and equivalents | $153.2M | $144.2M | $183.0M | $86.5M | $199.7M |
| Current assets | $311.5M | $367.9M | $365.3M | $311.7M | $271.4M |
| Total assets | $451.7M | $509.5M | $488.7M | $418.8M | $345.8M |
| Current liabilities | $68.5M | $70.3M | $65.0M | $51.7M | $48.8M |
| Total liabilities | $107.5M | $112.2M | $102.7M | $82.7M | $87.2M |
| Stockholders' equity | $344.2M | $397.3M | $386.0M | $336.1M | $261.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$34.2M | $15.7M | $14.6M | $35.7M | $44.0M |
| Depreciation and amortization | $8.3M | $6.9M | $5.1M | $4.5M | $3.6M |
| Stock-based compensation | $30.6M | $27.2M | $23.5M | $20.4M | $14.6M |
| Capital expenditure | $5.8M | $23.4M | $18.2M | $18.1M | $13.6M |
| Free cash flow | -$40.0M | -$7.7M | -$3.6M | $17.6M | $30.3M |
| Share repurchases | $6.5M | — | — | — | — |
| Impairments | — | — | $154,000 | — | — |
Shares outstanding 49.5M · Free float 33.8%
Annual filing data through FY ended January 2, 2026; float as of July 8, 2026.